306
Participants
Start Date
February 4, 2009
Primary Completion Date
January 9, 2012
Study Completion Date
January 16, 2014
carboplatin
Given IV
cediranib maleate
Given orally
paclitaxel
Given IV
placebo
Given orally
Instituto Nacional de Cancer (INCA), Rio de Janeiro
Instituto de Cancer Arnaldo Vieira de Carvalho, São Paulo
Tom Baker Cancer Centre, Calgary
Cross Cancer Institute, Edmonton
BCCA - Abbotsford Centre, Abbotsford
BCCA - Fraser Valley Cancer Centre, Surrey
BCCA - Vancouver Cancer Centre, Vancouver
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
Cancer Centre of Southeastern Ontario at Kingston, Kingston
London Regional Cancer Program, London
Ottawa Health Research Institute - General Division, Ottawa
Algoma District Cancer Program, Sault Ste. Marie
Niagara Health System, St. Catharines
Mount Sinai Hospital, Toronto
Univ. Health Network-Princess Margaret Hospital, Toronto
Windsor Regional Cancer Centre, Windsor
McGill University - Dept. Oncology, Montreal
University Institute of Cardiology and, Québec
Allan Blair Cancer Centre, Regina
Lead Sponsor
NCIC Clinical Trials Group
NETWORK